GUELPH, ON, Feb. 29, 2012 /CNW/ - Dr Brenda Coomber, a Guelph researcher
investigating an innovative way to improve treatment for colon cancer,
is one of 10 Ontario-based scientists receiving new funding, the
Canadian Cancer Society announced today.
"This funding helps us work towards solving a problem for cancer
patients in an unconventional way," says Dr Coomber, who is leading the
project at the University of Guelph.
The drug Avastin works by starving cancer cells of their blood supply,
but unfortunately the therapy doesn't work for everyone and there is no
way of telling which patients will benefit.
Dr Coomber and her team have proposed a way to tackle this problem and
will be using the new funding to study how to identify which patients
will respond and how to make the drug more effective. This is important
because it may lead to more patients surviving colon cancer.
Being able to identify the patients who would benefit from this drug
while improving a tumour's sensitivity to Avastin through Dr Coomber's
innovative approach landed her top scores in the Society's first
Innovation Grants competition.
An estimated 3,250 Ontarians died of colorectal cancer in 2011 and 8,100
were diagnosed with the disease. Colon cancer is the second biggest
cancer killer of Canadians.
"We are funding unique and creative research projects to stimulate new
approaches in cancer research, the kind that have the potential to turn
cancer on its head," says Lorraine Skarratt, manager of the Society's
Wellington County Unit. "In this way and with the support of our donors
and volunteers, we lead the way in the fight against cancer."
The Society's new Innovation Grants were developed to support innovative
and creative problem-solving in cancer research. The goal is to support
unconventional concepts, approaches or methodologies to address
problems in cancer research.
Dr Coomber is receiving nearly $200,000 over two years for this project.
Including this new grant, she has received more than $1.1 million in
funding from the Canadian Cancer Society since 2000. In total,
researchers at the University of Guelph have been awarded more than
$1.5 million since 2008.
A total of 23 grants representing a $4.5 million investment were
announced today across the country. For more information about the
Society's research funding, visit www.cancer.ca.
The Canadian Cancer Society is a national community-based organization
of volunteers whose mission is the eradication of cancer and the
enhancement of the quality of life of people living with cancer. When
you want to know more about cancer, visit our website www.cancer.ca or
call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.
SOURCE Canadian Cancer Society (Ontario Division)
For further information:
or to arrange an interview:
Canadian Cancer Society, Ontario Division
(416) 323-7030; email@example.com